Business Context and Reporting Period
This Form 8-K was filed by Pono Capital Two, Inc. on June 22, 2023, reporting an event dated June 21, 2023. Although the requested company is SBC Medical Group Holdings Inc., the filing registrant is Pono Capital Two, the SPAC proposing to combine with SBC.
The filing reports entry into an Amended and Restated Agreement and Plan of Merger with SBC Medical Group Holdings Incorporated, Pono Two Merger Sub, and related representatives.
Key Financial Metrics and Liquidity
The filing does not provide financial statements, revenue, profit, cash flow, margins, debt, liquidity, or other operating metrics for SBC or Pono.
The filing notes that future capital needs, liquidity, results of operations, financial condition, revenue, capital expenditures, enterprise value, and redemption levels remain subject to uncertainty.
Material Changes Versus the Prior Agreement
- The transaction scope was revised following a restructuring of SBC’s corporate structure.
- Pono will acquire only the Service Companies and Other Entities, and will no longer directly or indirectly acquire SBC’s Medical Corporations.
- References, representations, and warranties relating to the Medical Corporations were removed or revised accordingly.
- SBC is expected to complete and deliver disclosure schedules by August 31, 2023.
- Pono may terminate the agreement during a two-business-day period after delivery if the schedules are not timely delivered or disclose matters that Pono reasonably determines are materially adverse to the target companies.
- The expected closing deadline was extended from September 30, 2023, subject to extension, to December 31, 2023.
- Future expenses associated with extending Pono’s deadline to complete its initial business combination will be borne entirely by Pono, replacing the prior requirement that Pono and SBC share those expenses equally.
Outlook, Risks, and Unusual Items
Completion of the business combination remains subject to customary conditions, including Pono stockholder approval, satisfaction of closing conditions, potential regulatory or legal developments, and compliance with Nasdaq initial listing standards.
Identified risks include excessive shareholder redemptions, failure to obtain additional capital on acceptable terms, disruption to SBC’s business, inability to realize expected transaction benefits, insufficient financial information for reliable forecasts, legal proceedings, and termination of the merger agreement.
The filing contains forward-looking statements regarding the transaction and the expected financial and business benefits. It states that actual results may differ materially and that neither Pono nor SBC undertakes to update such statements except as required by law.
The filing is not itself a proxy solicitation, offer to sell, or offer to buy securities. Pono intends to file a proxy statement and related materials with the SEC.
Investor Verification Items
- Verify the final scope of entities to be acquired and the terms of the Amended and Restated Merger Agreement.
- Review SBC’s disclosure schedules when filed and assess whether Pono exercises its termination right.
- Confirm whether Pono stockholders approve the transaction and monitor expected redemption levels.
- Confirm whether the transaction closes by December 31, 2023, or whether the deadline is further amended.
- Review the future proxy statement for audited financial statements, valuation, capitalization, projected financial information, and detailed risk factors.
- Assess the effect of Pono bearing future extension expenses and any additional financing requirements.